Effective bone healing relies on the activation of immune and mesenchymal stem cells (MSCs). Recent research shows that preconditioning MSCs in inflammatory environments can enhance their ability to promote osteoblast differentiation, crucial for bone repair. Additionally, the potential of platelet-rich plasma (PRP) in this healing process has been established, highlighting the complex interplay between inflammation and recovery.
